english: On March 8, 2018, Amgen Inc. (“Amgen”) filed suit against Adello Biologics, LLC (“Adello”) in the District of New Jersey, alleging infringement of seventeen patents: U.S. Patent Nos. 6,180,391; 7,083,948; 7,118,884; 7,384,765; 7,427,659; 7,662,930; 7,735,525; 7,781,395; 8,191,566; 8,273,707; 8,940,878; 8,952,138; 9,418,416; 9,632,095; 9,643,997; 9,704,239; and 9,856,287.
non_english: BAA-KE5A BAA-KE5B BAA-KE5C BAA-KE5D BAA-KE5E BAA-KE5F BAA-KE5G BAA-KE5H BAA-KE5I BAA-KE5J BAA-KE5K BAA-KE5L BAA-KE5M BAA-KE5N BAA-KE5O BAA-KE5P BAA-KE5Q BAA-KE5R BAA-KE5S BAA-KE5T BAA-KE5U BAA-KE5V BAA-KE5W BAA-KE5X BAA-KE5Y BAA-KE5Z BAA-KE50 BAA-KE51 BAA-KE52 BAA-KE53 BAA-KE54 BAA-KE55 BAA-KE56 BAA-KE57 BAA-KE58 BAA-KE59